Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-4 of 4 for your search:
Drug:
liothyronine sodium
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
Phase:
Phase IV
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
Dathyrca 1
, EudrCT 2007-002713-39, HB-2007-043, Data register 2007-41-120, NCT00604318
2.
Phase III Randomized Study of Remnant Ablation With High- Versus Low-Dose Iodine I 131 With Versus Without Recombinant Thyroid-Stimulating Hormone in Patients Who Have Undergone Total Thyroidectomy for Differentiated Thyroid Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
16 to 80
Sponsor:
Other
Protocol IDs:
CRUK-HILO-BRD/05/83
, ISRCTN56078540, EU-20665, CTA-20363/0217/001/0001, EUDRACT-2005-003687-37, NCT00415233
3.
Phase I Study of In Situ Gene Therapy With Intraprostatic Injection of Ad5CMV-NIS and Oral iodine I 131 In Patients With Locally Recurrent Adenocarcinoma of the Prostate That Failed External Beam Radiotherapy
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-MC0252
, MC0252, NCT00788307
4.
Evaluation Study of L-T3 Utility in the Follow-Up of Patients With Thyroid Cancer
Phase:
No phase specified
Type:
Diagnostic, Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CRC 03-52-R1
, NCT00223158
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute